Steven Cohen Leap Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$6.52 - $9.13 $494,789 - $692,857	-75,888 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.76 - $10.01 $328,454 - $486,365	48,588 Added 177.98%	75,888 $683,000
Q1 2018 May 15, 2018	BUY	$6.06 - $8.54 $165,438 - $233,141	27,300 New	27,300 $227,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $255M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.